Incidence of and Risk Factors for Postoperative Hyphema After 23-Gauge Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

References

• Brandt MT, Haug RH. Traumatic hyphema: a comprehensive review. J Oral Maxillofac Surg. 2001;59(12):1462–1470. doi:10.1053/joms.2001.28284
   PubMed Web of Science ®Google Scholar
• Iftikhar M, Mir T, Seidel N, et al. Epidemiology and outcomes of hyphema: a single tertiary centre experience of 180 cases. Acta Ophthalmol. 2021;99(3):e394–e401. doi:10.1111/aos.14603
   PubMed Web of Science ®Google Scholar
• Sankar PS, Chen TC, Grosskreutz CL, Pasquale LR. Traumatic hyphema. Int Ophthalmol Clin. 2002;42(3):57–68. doi:10.1097/00004397-200207000-00008
   PubMedGoogle Scholar
• Alkawas AA, Shahien EA, Hussein AM. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. J Glaucoma. 2010;19(9):622–626. doi:10.1097/IJG.0b013e3181ccb794
   PubMed Web of Science ®Google Scholar
• Hong JW, Choi GJ. Ahmed valve implantation for refractory glaucoma following pars plana vitrectomy. Korean J Ophthalmol. 2005;19(4):293–296. doi:10.3341/kjo.2005.19.4.293
   PubMedGoogle Scholar
• Buffault J, Graber M, Bensmail D, et al. Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep. 2020;10(1):4527. doi:10.1038/s41598-020-61319-1
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhao M, Xu M, et al. Outcomes of therapeutic keratoplasty for severe infectious keratitis in Chongqing, a 16-year experience. Infect Drug Resist. 2019;12:2487–2493. doi:10.2147/IDR.S204025
   PubMed Web of Science ®Google Scholar
• Sharma U, Sharma B, Kumar K, Kumar S. Evaluation of complications and visual outcome in various nucleus delivery techniques of manual small incision cataract surgery. Indian J Ophthalmol. 2019;67(7):1073–1078. doi:10.4103/ijo.IJO_1261_18
   PubMed Web of Science ®Google Scholar
• Zhuang M, Fan W, Xie P, Yuan ST, Liu QH, Zhao C. Evaluation of the safety and quality of day-case cataract surgery based on 4151 cases. Int J Ophthalmol. 2019;12(2):291–295.
   PubMed Web of Science ®Google Scholar
• Hasan SU, Rizvi SF, Mahmood SA, Zafar S, Hasan T. Anatomical outcome following indocyanine green assisted internal limiting membrane peeling for stage 3 and 4 macular hole surgery. J Coll Physicians Surg Pak. 2017;27(8):486–489.
   PubMed Web of Science ®Google Scholar
• Sayed KM, Naito T, Farouk MM, et al. Twenty five-gauge sutureless vitrectomy versus 20-gauge vitrectomy in epiretinal membrane surgery. J Med Invest. 2012;59(1–2):69–78. doi:10.2152/jmi.59.69
   PubMedGoogle Scholar
• Kung Y, Wu T. Risk factors of hyphema following surgeries for primary rhegmatogenous retinal detachment. Ophthalmologica. 2016;236(3):159–165. doi:10.1159/000452254
   PubMed Web of Science ®Google Scholar
• Bansal SMM, Gunasekeran DVM, Ang BM, et al. Controversies in the pathophysiology and management of hyphema. Surv Ophthalmol. 2016;61(3):297–308. doi:10.1016/j.survophthal.2015.11.005
   PubMed Web of Science ®Google Scholar
• Resnikoff S, Pascolini D, Etya’Ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851.
   PubMed Web of Science ®Google Scholar
• Fong DS, Aiello LP, Ferris FR, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27(10):2540–2553. doi:10.2337/diacare.27.10.2540
   PubMed Web of Science ®Google Scholar
• Jampol LM, Glassman AR, Sun J. Evaluation and care of patients with diabetic retinopathy. N Engl J Med. 2020;382(17):1629–1637. doi:10.1056/NEJMra1909637
   PubMed Web of Science ®Google Scholar
• Yau GL, Silva PS, Arrigg PG, Sun JK. Postoperative complications of pars plana vitrectomy for diabetic retinal disease. Semin Ophthalmol. 2018;33(1):126–133.
   PubMed Web of Science ®Google Scholar
• Chung TY, Chung H, Lee JH. Combined surgery and sequential surgery comprising phacoemulsification, pars plana vitrectomy, and intraocular lens implantation: comparison of clinical outcomes. J Cataract Refract Surg. 2002;28(11):2001–2005. doi:10.1016/S0886-3350(02)01354-8
   PubMed Web of Science ®Google Scholar
• Zaman Y, Rehman AU, Memon AF. Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy. Pak J Med Sci. 2013;29(2):590–592. doi:10.12669/pjms.292.3044
   PubMed Web of Science ®Google Scholar
• Oshima Y, Shima C, Wakabayashi T, et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology. 2009;116(5):927–938. doi:10.1016/j.ophtha.2008.11.005
   PubMed Web of Science ®Google Scholar
• Nakatake S, Yoshida S, Nakao S, et al. Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis. BMC Ophthalmol. 2014;14:55. doi:10.1186/1471-2415-14-55
   PubMed Web of Science ®Google Scholar
• Kojima S, Inatani M, Shobayashi K, Haga A, Inoue T, Tanihara H. Risk factors for hyphema after trabeculectomy with mitomycin C. J Glaucoma. 2014;23(5):307–311. doi:10.1097/IJG.0b013e3182741c85
   PubMed Web of Science ®Google Scholar
• Saito Y, Higashide T, Takeda H, Ohkubo S, Sugiyama K. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol. 2010;88(1):96–102. doi:10.1111/j.1755-3768.2009.01648.x
   PubMed Web of Science ®Google Scholar
• Gharaibeh A, Savage HI, Scherer RW, Goldberg MF, Lindsley K. Medical interventions for traumatic hyphema. Cochrane Database Syst Rev. 2019;1:D5431.
   Google Scholar
• Trivedi D, Denniston AK, Murray PI. Safety profile of anterior chamber paracentesis performed at the slit lamp. Clin Exp Ophthalmol. 2011;39(8):725–728. doi:10.1111/j.1442-9071.2011.02565.x
   PubMed Web of Science ®Google Scholar
• Newman DK. Surgical management of the late complications of proliferative diabetic retinopathy. Eye. 2010;24(3):441–449. doi:10.1038/eye.2009.325
   PubMed Web of Science ®Google Scholar
• Quiroz-Mercado H, Garza-Karren CD, Roigmelo EA, Jimenez-Sierra JM, Dalma-Weiszhausz J. Vitreous management in massive suprachoroidal hemorrhage. Eur J Ophthalmol. 1997;7(1):101–104. doi:10.1177/112067219700700117
   PubMedGoogle Scholar
• Lakhanpal V, Schocket SS, Elman MJ, Nirankari VS. A new modified vitreoretinal surgical approach in the management of massive suprachoroidal hemorrhage. Ophthalmology. 1989;96(6):793–800. doi:10.1016/S0161-6420(89)32819-3
   PubMed Web of Science ®Google Scholar
• Katz J, Feldman MA, Bass EB, et al. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology. 2003;110(9):1784–1788. doi:10.1016/S0161-6420(03)00785-1
   PubMed Web of Science ®Google Scholar
• Li Q, Shen X, Wang S, et al. Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage? Int Ophthalmol. 2020;40:2023–2029.
   PubMed Web of Science ®Google Scholar
• Louison S, Gabrielle PH, Soudry A, et al. Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study. Acta Ophthalmol. 2020;98. doi:10.1111/aos.14434
   PubMed Web of Science ®Google Scholar